Disease control rate (DRC) of bronchial asthma during pregnancy

Abstract

In recent years doctors from all around the world paying the high attention to the treatment of bronchial asthma in gestation during pregnancy. The main aim of this research is to get a better knowledge how the DCR of bronchial asthma in gestation during pregnancy influence the course of pregnancy, the fetus and the newborns. The research involves the explorations, descriptions of the bronchial asthmas clinical features, pregnancy and birth outcomes, newborns health (290 women who suffer from bronchial asthma were tested). The information was received through Asthma Control Test. Research results:

1 62.5% of the patients had have uncontrolled asthma;

2 37.5% of the patients had have controlled asthma;

The 1st group of the patients (51.7%) took control drugs (28% - cromones; 63,3% - inhalation corticosteroids; 8,7% – prednisolonum), the 2nd group of the patients (31%) because of the pregnancy took emergency drugs. The patients from the 1st group had had better respiratory function than the patients from the 2nd group (p<0.05). The patients from the 2nd group had had the complications of pregnancy like the threat of termination of pregnancy (2 occasions), early pregnancy toxicosis (2.9 occasions),the gestosis (2 occasions), chronic fetoplacental insufficiency (1.4 occasions), chronic prenatal hypoxia (1.3 occasions), cerebral ischemia, prenatal developmental delays, prenatal infection (p<0.05).

To sum up, the optimal asthma control during pregnancy will help in prevention of gestational complications and descendants’ health improvement.